Published in J Clin Invest on June 01, 1987
Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest (1988) 1.52
Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest (1993) 1.16
Epidermolysis bullosa acquisita. Clin Dermatol (2011) 1.14
Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen. Autoimmunity (2011) 0.85
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (1962) 64.93
Fibronectin: current concepts of its structure and functions. Coll Relat Res (1981) 4.82
Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med (1978) 3.46
Laminin receptor on human breast carcinoma cells. Proc Natl Acad Sci U S A (1983) 3.32
Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. J Biol Chem (1980) 2.53
Gene amplification in a single cell cycle in Chinese hamster ovary cells. J Biol Chem (1984) 2.32
Self-assembly of basement membrane collagen. Biochemistry (1984) 2.19
Role of fibronectin in collagen deposition: Fab' to the gelatin-binding domain of fibronectin inhibits both fibronectin and collagen organization in fibroblast extracellular matrix. J Cell Biol (1982) 1.89
Complexing of fibronectin glycosaminoglycans and collagen. Biochim Biophys Acta (1980) 1.87
Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med (1984) 1.80
Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol (1971) 1.57
Interactions of basement membrane components. Biochim Biophys Acta (1983) 1.57
Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol (1981) 1.55
Arrangement of attachment-promoting, self-association, and heparin-binding sites in horse serum fibronectin. J Biol Chem (1982) 1.38
Characterization of a novel collagen chain in human placenta and its relation to AB collagen. Biochemistry (1979) 1.28
Epidermolysis bullosa acquisita with electron microscopical studies. Arch Dermatol (1975) 1.26
Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts. J Invest Dermatol (1985) 1.12
Spreading and enhanced motility of human keratinocytes on fibronectin. J Invest Dermatol (1985) 1.12
Fibronectin: its relationship to basement membranes. I. Light microscopic studies. Coll Relat Res (1981) 1.08
Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. Br J Dermatol (1980) 1.05
Monoclonal antibody to type IV collagen with selective basement membrane localization. Lab Invest (1984) 1.05
Epidermolysis bullosa acquisita antigen, a major cutaneous basement membrane component, is synthesized by human dermal fibroblasts and other cutaneous tissues. J Invest Dermatol (1986) 1.05
A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1985) 0.98
Epidermolysis bullosa acquisita antigen is synthesized by human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun (1985) 0.93
Production of soluble and cell-associated fibronectin by cultured keratinocytes. J Invest Dermatol (1984) 0.92
Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains. J Invest Dermatol (1986) 0.88
The specific detection of collagenous proteins after electrophoresis using enzyme-conjugated collagen-binding fibronectin fragments. Anal Biochem (1982) 0.86
Organ-specific, phylogenetic, and ontogenetic distribution of the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1986) 0.83
Epidermolysis bullosa acquisita. Arch Dermatol (1981) 0.78
Interaction between fluorescence-labeled fibronectin fragments studied by gel high-performance liquid chromatography. J Chromatogr (1985) 0.77
Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol (1989) 5.69
Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A (1991) 4.61
Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J Biol Chem (1996) 4.45
Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest (2000) 4.33
The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol (1991) 3.35
Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem (1999) 3.34
An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis (1989) 3.12
Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol (1991) 2.79
Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. J Biol Chem (1980) 2.53
Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem (1998) 2.50
Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell (1995) 2.36
Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Biol Chem (1988) 2.23
In vivo and in vitro observations on laminin production by Schwann cells. Proc Natl Acad Sci U S A (1983) 2.10
Fibronectin's cell-adhesive domain and an amino-terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix. J Biol Chem (1987) 2.03
Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol (1988) 2.00
Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97
Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J Biol Chem (1998) 1.96
A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development (2001) 1.92
Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. J Clin Invest (1982) 1.90
The fibronectin receptor is organized by extracellular matrix fibronectin: implications for oncogenic transformation and for cell recognition of fibronectin matrices. J Cell Biol (1989) 1.89
Role of fibronectin in collagen deposition: Fab' to the gelatin-binding domain of fibronectin inhibits both fibronectin and collagen organization in fibroblast extracellular matrix. J Cell Biol (1982) 1.89
Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol (1984) 1.85
Epidermolysis bullosa dystrophica-recessive: a possible role of anchoring fibrils in the pathogenesis. J Invest Dermatol (1975) 1.80
Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med (1984) 1.80
Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. Proc Natl Acad Sci U S A (1991) 1.66
Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol (1984) 1.61
Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. JAMA (1992) 1.60
The epidermal-dermal junction. J Invest Dermatol (1975) 1.60
Nck/Dock: an adapter between cell surface receptors and the actin cytoskeleton. Oncogene (2001) 1.57
Interactions of basement membrane components. Biochim Biophys Acta (1983) 1.57
Lesch-Nyhan syndrome: altered kinetic properties of mutant enzyme. Science (1971) 1.56
Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol (1981) 1.55
A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts. Detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis. J Clin Invest (1986) 1.54
Human glutamine phosphoribosylpyrophosphate amidotransferase. Kinetic and regulatory properties. J Biol Chem (1973) 1.53
Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest (1988) 1.52
Degradation of newly synthesized collagen. J Biol Chem (1978) 1.52
Congenital localized absence of the skin as a manifestation of epidermolysis bullosa. Arch Dermatol (1992) 1.51
The alpha 5 beta 1 integrin fibronectin receptor, but not the alpha 5 cytoplasmic domain, functions in an early and essential step in fibronectin matrix assembly. J Biol Chem (1993) 1.49
Formation and origin of basal lamina and anchoring fibrils in adult human skin. J Cell Biol (1971) 1.48
Laminin inhibits human keratinocyte migration. J Cell Physiol (1988) 1.46
Hailey-Hailey disease is not allelic to Darier's disease. J Invest Dermatol (1994) 1.40
Autosomal dominantly inherited generalized basaloid follicular hamartoma syndrome: report of a new disease in a North Carolina family. J Am Acad Dermatol (2000) 1.39
Characterization of cellular elements in healed cultured keratinocyte autografts used to cover burn wounds. Arch Dermatol (1990) 1.39
Enhanced modulation of keratinocyte motility by transforming growth factor-alpha (TGF-alpha) relative to epidermal growth factor (EGF). J Invest Dermatol (1996) 1.39
Cutaneous plasmacytomas. A review and presentation of an unusual case. J Am Acad Dermatol (1979) 1.38
Leukokeratoderma estrovale digitorum inversa. J Am Acad Dermatol (1996) 1.38
Fibronectin's amino-terminal matrix assembly site is located within the 29-kDa amino-terminal domain containing five type I repeats. J Biol Chem (1988) 1.37
Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin. J Biol Chem (1997) 1.37
Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cells. Exp Cell Res (1983) 1.36
Calcium-induced assembly of adherens junctions in keratinocytes. J Cell Biol (1987) 1.36
Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol (1999) 1.34
Identification of a new biological function for the integrin alpha v beta 3: initiation of fibronectin matrix assembly. Cell Adhes Commun (1996) 1.34
Human alveolar macrophage fibronectin: synthesis, secretion, and ultrastructural localization during gelatin-coated latex particle binding. J Cell Biol (1981) 1.32
Epidermal growth factor receptor number decreases during rat liver regeneration. J Clin Invest (1981) 1.32
Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol (1998) 1.31
Hypoxia increases human keratinocyte motility on connective tissue. J Clin Invest (1997) 1.27
A novel role for alpha 3 beta 1 integrins in extracellular matrix assembly. J Cell Sci (1995) 1.25
Destruction of a major extracellular adhesive glycoprotein (fibronectin) of human fibroblasts by neutral proteases from polymorphonuclear leukocyte granules. Lab Invest (1979) 1.25
Molecular cloning and characterization of a putative mouse hyaluronan synthase. J Biol Chem (1996) 1.24
Epidermal growth factor (EGF) promotes human keratinocyte locomotion on collagen by increasing the alpha 2 integrin subunit. Exp Cell Res (1993) 1.24
Nckbeta adapter regulates actin polymerization in NIH 3T3 fibroblasts in response to platelet-derived growth factor bb. Mol Cell Biol (2000) 1.24
A model of cell cycle control: sequential events regulated by growth factors. Mol Cell Endocrinol (1983) 1.23
An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J Invest Dermatol (1982) 1.23
Assembly of extracellular matrix. Curr Opin Cell Biol (1992) 1.22
Diff-Quik stain for Tzanck smears. J Am Acad Dermatol (1985) 1.21
Orality, preference behavior, and reinforcement value of nonfood object in monkeys with orbital frontal lesions. Science (1969) 1.21
In vitro parasite-monocyte interactions in human leishmaniasis: possible role of fibronectin in parasite attachment. Infect Immun (1985) 1.21
Human keratinocyte locomotion: the effect of selected cytokines. J Invest Dermatol (1992) 1.21
Recessive dystrophic epidermolysis bullosa phenotype is preserved in xenografts using SCID mice: development of an experimental in vivo model. J Invest Dermatol (1992) 1.20
Molecular cloning and characterization of a cDNA encoding the third putative mammalian hyaluronan synthase. J Biol Chem (1997) 1.18
Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. A double-blind study. J Am Acad Dermatol (1986) 1.17
Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst (1996) 1.17
Differential proteolytic susceptibility of laminin alpha and beta subunits. Arch Biochem Biophys (1982) 1.16
Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest (1993) 1.16
Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis. Proc Natl Acad Sci U S A (1982) 1.16
Regulation of expression of fibronectin and its receptor, alpha 5 beta 1, during development and regeneration of peripheral nerve. Development (1992) 1.15
Laminin-5 inhibits human keratinocyte migration. Exp Cell Res (1997) 1.15
Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med (1984) 1.14
A case of linear IgA disease presenting initially with IgG immune deposits. J Am Acad Dermatol (1986) 1.14
Stem-loop SL4 of the HIV-1 psi RNA packaging signal exhibits weak affinity for the nucleocapsid protein. structural studies and implications for genome recognition. J Mol Biol (2001) 1.13
The role of alpha 4 beta 1 integrin in cell motility and fibronectin matrix assembly. J Cell Sci (1995) 1.13
Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies. Arch Dermatol (1995) 1.12
Spreading and enhanced motility of human keratinocytes on fibronectin. J Invest Dermatol (1985) 1.12
Epidermal-dermal interactions in adult human skin: role of dermis in epidermal maintenance. J Invest Dermatol (1968) 1.12
Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression. Mol Biol Cell (2000) 1.11
Gelatin-binding domain-specific anti-human plasma fibronectin Fab' inhibits fibronectin-mediated gelatin binding but not cell spreading. J Biol Chem (1981) 1.10
NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. J Invest Dermatol (1999) 1.10